Owners, management and financials
CVR: 40243224
Previous names: Tetramer Shop ApS
DKK 3,442,436
Gross profit
Net result: DKK 154,956
10x Genomics, Inc. (100%)
CVR · view owners
Adam Samuel Taich, James Sears Bryant
CVR · view management
Active
Founded 31 January 2019
CVR · view overview
2 employees
CVR · 2026
Director role ended: Eric Stewart Whitaker
CVR · 16/09/2025
View the full event history
10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.
Source: annual report 2025, Danish Business Authority
The financial health of 10x Genomics Denmark ApS shows significant volatility, particularly in gross profit and profitability over the past few years. After a peak gross profit of 52.2 million DKK in 2021, the company experienced a sharp decline, with gross profit dropping to 3.4 million DKK in 2024 and a profit of only 155,000 DKK. Equity has improved from 635,339 DKK in 2023 to 973,740 DKK in 2025, indicating a strengthening balance sheet, though the lack of disclosed revenue raises concerns about overall sales performance. The company operates within the pharmaceutical manufacturing sector, where maintaining profitability and managing operational costs will be crucial for future stability and growth.
AI-generated summary · Generated 12/08/2026
Selskabets formål er at fremstille og sælge instrumenter og forbrugsmaterialer til kunder, der beskæftiger sig med forsknings- og udviklingsaktiviteter inden for bioteknologi, liv og medicinsk videnskab.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.4 mio. | 155 t. | 1.6 mio. | 974 t. | - | |
| 202401/01/2024 – 31/12/2024 | 3.4 mio. | 183 t. | 1.4 mio. | 819 t. | 2 | |
| 202301/01/2023 – 31/12/2023 | 2.1 mio. | -587 t. | 2.3 mio. | 635 t. | 2 | |
| 202201/01/2022 – 31/12/2022 | 7.3 mio. | 2.8 mio. | 6.1 mio. | 1.2 mio. | 5 | |
| 202101/01/2021 – 31/12/2021 | 52.2 mio. | 39.8 mio. | 50.4 mio. | 38.4 mio. | 2 | |
| 202001/01/2020 – 31/12/2020 | -1.6 mio. | -2 mio. | 2.5 mio. | -1.4 mio. | 2 | |
| 201931/01/2019 – 31/12/2019 | 552 t. | 245 t. | 759 t. | 625 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of 10x Genomics Denmark ApS is 40243224.
10x Genomics Denmark ApS is owned by 10x Genomics, Inc..
The management of 10x Genomics Denmark ApS consists of Adam Samuel Taich and James Sears Bryant.
In 2025, 10x Genomics Denmark ApS reported a gross profit of DKK 3,442,436.
10x Genomics Denmark ApS had 2 employees in 2026 according to the Danish CVR register.
10x Genomics Denmark ApS was founded on 31 January 2019.
Claim this page to add your logo and social links. Free to get started.
10x Genomics Denmark ApS has published its annual report for 2025. Gross profit came to DKK 3,442,436, and the net result was DKK 154,956.
As of September 16, 2025, James Sears Bryant is registered as director of 10x Genomics Denmark ApS.
As of September 16, 2025, Eric Stewart Whitaker has stepped down as director of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS has published its annual report for 2024. Gross profit came to DKK 3,416,395, and the net result was DKK 183,445.
As of May 15, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 10x Genomics Denmark ApS.
As of August 28, 2024, Adam Samuel Taich is registered as director of 10x Genomics Denmark ApS.
As of August 28, 2024, Justin John McAnear has stepped down as director of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS has published its annual report for 2023. Gross profit came to DKK 2,058,991, and the net result was DKK -586,583.
10x Genomics Denmark ApS has won the tender "Cytassist - 2024-0687771" issued by Aarhus Universitet worth 96,851 EUR.
10x Genomics Denmark ApS has published its annual report for 2022. Gross profit came to DKK 7,333,851, and the net result was DKK 2,820,214.
As of November 18, 2022, Søren Nyboe Jakobsen has stepped down as director of 10x Genomics Denmark ApS.
On November 18, 2022, the company changed its name from Tetramer Shop ApS to 10x Genomics Denmark ApS.
10x Genomics Denmark ApS has published its annual report for 2021. Gross profit came to DKK 52,191,085, and the net result was DKK 39,803,587.
10x Genomics Denmark ApS has published its annual report for 2020. Gross profit came to DKK -1,602,244, and the net result was DKK -2,027,263.
As of January 8, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 10x Genomics Denmark ApS.
As of January 8, 2021, Søren Fogh Aagaard has left the board of directors of 10x Genomics Denmark ApS.
As of January 8, 2021, Søren Nyboe Jakobsen has left the board of directors of 10x Genomics Denmark ApS.
As of January 8, 2021, Sunil Kumar Saini has left the board of directors of 10x Genomics Denmark ApS.
As of January 8, 2021, Sebastian Hartmut Springer has left the board of directors of 10x Genomics Denmark ApS.
As of January 8, 2021, Søren Nyboe Jakobsen is registered as director of 10x Genomics Denmark ApS.
As of January 8, 2021, Eric Stewart Whitaker is registered as director of 10x Genomics Denmark ApS.
As of January 8, 2021, is registered as an owner of 10x Genomics Denmark ApS with an ownership share of 100%.
As of January 7, 2021, Søren Nyboe Jakobsen has stepped down as adm. dir. of 10x Genomics Denmark ApS.
As of January 1, 2021, Justin John McAnear is registered as director of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS has published its annual report for 2019. Gross profit came to DKK 552,190, and the net result was DKK 245,383.
As of April 2, 2019, Søren Fogh Aagaard has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Søren Nyboe Jakobsen has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Sunil Kumar Saini has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Sebastian Hartmut Springer has joined the board of directors of 10x Genomics Denmark ApS.
As of January 31, 2019, Søren Nyboe Jakobsen is registered as adm. dir. of 10x Genomics Denmark ApS.
10x Genomics Denmark ApS was founded on January 31, 2019.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 37812730
CVR 39315769
CVR 40169229
CVR 41257547
CVR 41372079
